litlas
Log inCreate account

Thomas W. Gardner

Active 1983–2025

74
Papers
19,379
Citations
59
h-index
73
i10-index

Citations

Citations per year for Thomas W. Gardner1990: 1 citations1991: 1 citations1993: 1 citations1994: 4 citations1995: 1 citations1996: 1 citations1997: 4 citations1998: 6 citations1999: 16 citations2000: 35 citations2001: 44 citations2002: 90 citations2003: 93 citations2004: 95 citations2005: 116 citations2006: 121 citations2007: 145 citations2008: 164 citations2009: 143 citations2010: 163 citations2011: 180 citations2012: 182 citations2013: 172 citations2014: 170 citations2015: 156 citations2016: 169 citations2017: 176 citations2018: 184 citations2019: 540 citations2020: 762 citations2021: 780 citations2022: 581 citations2023: 471 citations2024: 640 citations2025: 263 citations2026: 16 citations1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,901 citing papers, 28.5% of this breakdownChina: 922 citing papers, 13.8% of this breakdownUnited Kingdom: 393 citing papers, 5.9% of this breakdownItaly: 248 citing papers, 3.7% of this breakdownGermany: 247 citing papers, 3.7% of this breakdownIndia: 230 citing papers, 3.4% of this breakdownJapan: 228 citing papers, 3.4% of this breakdownAustralia: 220 citing papers, 3.3% of this breakdownSpain: 186 citing papers, 2.8% of this breakdownCanada: 157 citing papers, 2.4% of this breakdownSouth Korea: 135 citing papers, 2% of this breakdownFrance: 117 citing papers, 1.8% of this breakdown
0%28.5%Other 25.3%

Institutions

Fields

  • Medicine66.5%
  • Biochemistry, Genetics and Molecular Biology20.1%
  • Neuroscience7.1%
  • Environmental Science1.2%
  • Immunology and Microbiology1%
  • Engineering0.7%
  • Other3.4%

Topics

  • Retinal Diseases and Treatments17.5%
  • Retinal Imaging and Analysis8.6%
  • Glaucoma and retinal disorders3.8%
  • Retinal Development and Disorders3.2%
  • Advanced Glycation End Products research2.6%
  • Retinal and Optic Conditions2%
  • Other62.3%

Coauthors

All papers

Open in search
  1. Diabetic Retinopathy

    Authors: David A. Antonetti, Ronald Klein, Thomas W. Gardner - New England Journal of Medicine 2012 cited by 1,588

  2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update

    Authors: Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, Janet B. McGill, Sarah L. Berga, Michael A. Bush, Suchitra Chandrasekaran, Ralph A. DeFronzo, Daniel Einhorn, Rodolfo J. Galindo, Thomas W. Gardner, Rajesh Garg, W. Timothy Garvey, Irl B. Hirsch, Daniel L. Hurley, Kenneth Izuora, Mikhail Kosiborod, Darin E. Olson, Shailendra B. Patel, Rodica Pop‐Busui, Archana Sadhu, Susan L. Samson, Carla Stec, William V. Tamborlane, Katherine R. Tuttle, Christine Twining, Adrian Vella, Priyathama Vellanki, Sandra Weber - Endocrine Practice 2022 cited by 469

  3. Neurodegeneration in diabetic retinopathy: does it really matter?

    Authors: Rafael Simó, Alan W. Stitt, Thomas W. Gardner - Diabetologia 2018 cited by 573

  4. Diabetic Retinopathy: A Position Statement by the American Diabetes Association

    Authors: Sharon D. Solomon, Emily Y. Chew, Elia J. Duh, Lucia Sobrin, Jennifer K. Sun, Brian L. VanderBeek, Charles C. Wykoff, Thomas W. Gardner - Diabetes Care 2017 cited by 939

  5. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism

    Authors: Stéphanie Eid, Kelli M. Sas, Steven F. Abcouwer, Eva L. Feldman, Thomas W. Gardner, Subramaniam Pennathur, Patrice E. Fort - Diabetologia 2019 cited by 468

  6. Retinopathy in Diabetes

    Authors: Donald S. Fong, Lloyd Paul Aiello, Thomas W. Gardner, George L. King, George W. Blankenship, Jerry D. Cavallerano, Fredrick L. Ferris, Ronald Klein - Diabetes Care 2004 cited by 1,084

  7. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

    Authors: Alistair J. Barber, Erich Lieth, Sonny Khin, David A. Antonetti, Alexis Buchanan, Thomas W. Gardner - Journal of Clinical Investigation 1998 cited by 1,305

  8. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

    Authors: Jeffrey G. Gross, Adam R. Glassman, Danni Liu, Jennifer K. Sun, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, Michael J. Elman, Frederick L. Ferris, Thomas W. Gardner, Lee M. Jampol, Daniel Martín, Michele Melia, Cynthia R. Stockdale, Roy W. Beck - JAMA Ophthalmology 2018 cited by 387

  9. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications

    Authors: Kelli M. Sas, Pradeep Kayampilly, Jaeman Byun, Viji Nair, Lucy M. Hinder, Junguk Hur, Hongyu Zhang, Cheng‐mao Lin, Nathan Qi, George Michailidis, Per‐Henrik Groop, Robert G. Nelson, Manjula Darshi, Kumar Sharma, Jeffrey R. Schelling, John R. Sedor, Rodica Pop‐Busui, Joel M. Weinberg, Scott A. Soleimanpour, Steven F. Abcouwer, Thomas W. Gardner, Charles Burant, Eva L. Feldman, Matthias Kretzler, Frank C. Brosius, Subramaniam Pennathur - JCI Insight 2016 cited by 265

  10. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

    Authors: Dean P. Hainsworth, Ionut Bebu, Lloyd Paul Aiello, William I. Sivitz, Rose Gubitosi‐Klug, John I. Malone, Neil H. White, Ronald P. Danis, Amisha Wallia, Xiaoyu Gao, Andrew J. Barkmeier, Arup Das, Shriji Patel, Thomas W. Gardner, John M. Lachin - Diabetes Care 2019 cited by 194

  11. Retinal angiogenesis in development and disease

    Authors: Ray F. Gariano, Thomas W. Gardner - Nature 2005 cited by 728

  12. Minocycline Reduces Proinflammatory Cytokine Expression, Microglial Activation, and Caspase-3 Activation in a Rodent Model of Diabetic Retinopathy

    Authors: J. Kyle Krady, Anirban Basu, Colleen Allen, Yuping Xu, Kathryn F. LaNoue, Thomas W. Gardner, Steven W. Levison - Diabetes 2005 cited by 526

  13. Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians

    Authors: Farsad Afshinnia, Viji Nair, Jiahe Lin, Thekkelnaycke M. Rajendiran, Tanu Soni, Jaeman Byun, Kumar Sharma, Patrice E. Fort, Thomas W. Gardner, Helen C. Looker, Robert G. Nelson, Frank C. Brosius, Eva L. Feldman, George Michailidis, Matthias Kretzler, Subramaniam Pennathur - JCI Insight 2019 cited by 122

  14. Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1

    Authors: David A. Antonetti, Alistair J. Barber, Leigh Ann Hollinger, E Wolpert, Thomas W. Gardner - Journal of Biological Chemistry 1999 cited by 678

  15. The Significance of Vascular and Neural Apoptosis to the Pathology of Diabetic Retinopathy

    Authors: Alistair J. Barber, Thomas W. Gardner, Steven F. Abcouwer - Investigative Ophthalmology & Visual Science 2011 cited by 437

  16. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment

    Authors: Steven F. Abcouwer, Thomas W. Gardner - Annals of the New York Academy of Sciences 2014 cited by 267

  17. Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease

    Authors: Michael D. Abràmoff, Patrice E. Fort, Ian C. Han, Thiran Jayasundera, Elliott H. Sohn, Thomas W. Gardner - Investigative Ophthalmology & Visual Science 2018 cited by 106

  18. The neurovascular unit and the pathophysiologic basis of diabetic retinopathy

    Authors: Thomas W. Gardner, José Dávila - Graefe s Archive for Clinical and Experimental Ophthalmology 2016 cited by 188

  19. Diabetic Retinopathy

    Authors: David A. Antonetti, Alistair J. Barber, Sarah K. Bronson, Willard M. Freeman, Thomas W. Gardner, Leonard S. Jefferson, Mark Kester, Scot R. Kimball, J. Kyle Krady, Kathryn F. LaNoue, Christopher C. Norbury, Patrick G. Quinn, Lakshman Sandirasegarane, Ian A. Simpson - Diabetes 2006 cited by 738

  20. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States

    Authors: Sophia Y. Wang, Chris Andrews, William H. Herman, Thomas W. Gardner, Joshua D. Stein - Ophthalmology 2016 cited by 155

  21. Predicting Development of Proliferative Diabetic Retinopathy

    Authors: Kristen Nwanyanwu, Nidhi Talwar, Thomas W. Gardner, James S. Wrobel, William H. Herman, Joshua D. Stein - Diabetes Care 2012 cited by 131

  22. Updating the Staging System for Diabetic Retinal Disease

    Authors: Jennifer K. Sun, Lloyd Paul Aiello, Michael D. Abràmoff, David A. Antonetti, Sanjoy Dutta, Marlon Pragnell, S. Robert Levine, Thomas W. Gardner - Ophthalmology 2020 cited by 95

  23. The Ins2AkitaMouse as a Model of Early Retinal Complications in Diabetes

    Authors: Alistair J. Barber, David A. Antonetti, Timothy S. Kern, Chad E.N. Reiter, Rohit Soans, J. Kyle Krady, Steven W. Levison, Thomas W. Gardner, Sarah K. Bronson - Investigative Ophthalmology & Visual Science 2005 cited by 472

  24. Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy

    Authors: Katherine A. Joltikov, Christopher Sesi, Vinicius Castro, José Dávila, Rohit Anand, Sami M. Khan, Neil Farbman, Gregory R. Jackson, Chris A. Johnson, Thomas W. Gardner - Investigative Ophthalmology & Visual Science 2018 cited by 98